Back to search

Article

Patients with Colon Cancer Benefit from Using the Therapeutic Target lncRNA GAPLINC

2023-02-08

Abstract excerpt

<h4>Background: </h4> According to recent reports, some cancer subtypes have increased GAPLINC expression. The invasion and dissemination of cancer cells may be facilitated by GAPLINC expression. However, the therapeutic utility of GAPLINC in colon cancer (COAD) has not been studied. <h4>Materials: </h4> /Methods: We evaluated the mRNA expression of GAPLINC in COAD patients using data from the Cancer Genome Map t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a607d7aa-a76e-55ee-9148-b6180e0bdb05
DOI
10.21203/rs.3.rs-2549650/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Patients with Colon Cancer Benefit from Using the Therapeutic Target lncRNA GAPLINCDOI 10.21203/rs.3.rs-2549650/v1
Select a neighboring publication to make it the new centre.